ArticleEuropean journal of pediatrics2025
Club cell secretory protein (CC16) polymorphisms in preterm neonates with respiratory distress syndrome and bronchopulmonary dysplasia.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the genotype frequencies of club cell secretory protein (CC16) polymorphisms in preterm neonates and explore their association with respiratory distress syndrome (RDS), and bronchopulmonary dysplasia (BPD). A prospective cohort study was conducted including 187 preterm neonates of ≤ 34 weeks of gestational age. Genotype frequencies of rs4963506, rs12270961, and rs3741240 CC16 polymorphisms were detected, comparing the CC16 polymorphisms between neonates with versus without RDS, and with versus without BPD. Serum CC16 was measured, when available, on the first and fourteenth postnatal days. A significant association of increased risk of RDS was detected for the homozygous GG rs4963506 variant (OR 3.03, 95%CI 1.36-6.75, p = 0.021), and the homozygous GG rs12270961 variant (OR 2.88, 95%CI 1.31-6.28, p = 0.024), but not for the homozygous GG rs3741240 variant, after adjusting for gestational age, mode of delivery, and antenatal administration of steroids. The homozygous GG rs4963506 variant was also associated with higher serum levels of CC16 compared to the GA/AA rs4963506 variants, on the first postnatal day. No associations between BPD and the genotype frequencies of any polymorphisms were detected.
conclusionIn preterm neonates, the homozygous GG rs4963506 and rs12270961 variants were both substantially associated with a higher risk of RDS. Further studies are warranted to validate our findings and explore the potential role of CC16 polymorphism detection in neonates at risk of respiratory morbidities. WHAT IS KNOWN: ∙ Serum club cell secretory protein (CC16) reflects the lung's developmental maturation and healing mechanisms for tissue damage. ∙ The CC16 polymorphisms have been inconsistently associated with lung function in children. ∙ No evidence exists regarding the association between CC16 polymorphisms and respiratory morbidity in neonates. WHAT IS NEW: ∙ Homozygous GG rs4963506 and GG rs12270961variants were associated with increased risk of respiratory distress in neonates. ∙ Homozygous GG rs4963506 variant was also associated with higher serum levels of CC16 on the first postnatal day. ∙ No associations between BPD and the genotype frequencies of any polymorphisms were detected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.